The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Embleema Secures $5 Million DoD Contract to Develop Global Pathogen Bio Surveillance Infrastructure
Sep 29, 2025•9 months ago
Contract Type
contract
BostonBiotechnologyHealth Carehospital & health care
Description
Embleema, in partnership with GRAVL and Aria Diagnostics, has been awarded a $5 million Department of Defense contract. This contract aims to launch the ANTIDOTE platform for decentralized biosurveillance, facilitating rapid responses to health threats through a globally connected genomic network.
Company Information
Company
Embleema
Location
44 West 28th Street
Boston, Massachusetts, United States
About
Embleema is a biotechnology company that focuses on innovative solutions for biosurveillance and biosecurity. They develop advanced platforms for real-time pathogen detection and analytics. The company leverages FDA-developed technologies to enhance global health surveillance capabilities.
BostonBiotechnologyHealth Carehospital & health care